OTR Acquisition Corp. (OTRAU)
Price:
9.55 USD
( - -1.99 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Centurion Acquisition Corp.
VALUE SCORE:
5
2nd position
Melar Acquisition Corp. I
VALUE SCORE:
11
The best
M3-Brigade Acquisition V Corp. Units
VALUE SCORE:
11
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
DESCRIPTION
As of May 19, 2022, OTR Acquisition Corp. was acquired by Comera Life Sciences Holdings, Inc., in a reverse merger transaction. OTR Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Miami, Florida.
NEWS
6 Stocks Halted In Wednesday's Session: Here's Why
benzinga.com
2022-05-18 17:36:01A circuit breaker is an automatic, temporary trading halt on certain securities when the underlying stock is experiencing times of high volatility. It is a measure put in place to help restore and bring order to the markets.
Biologic Medicines-Focused Comera Life Sciences Turns To SPAC For NASDAQ Debut
benzinga.com
2022-01-31 14:52:51Comera Life Sciences Inc has agreed to go public through a merger with OTR Acquisition Corp (NASDAQ: OTRA), a blank-check company. The combined company will have an initial equity value of about $258.4 million.
U.S. IPO Weekly Recap: Breast Cancer Biotech Pops 158% In A 6-IPO Week
seekingalpha.com
2020-11-22 13:07:23In a scramble to go public ahead of the holiday, six IPOs and 15 SPACs went public this past week led by breast cancer biotech Olema Pharmaceuticals, which soared 158% on its first day. New filings continued to pour in, priming the IPO pipeline for an active end to 2020.
U.S. IPO Weekly Recap: Biotechs And SPACs Ride The Summer Wave In A 4 IPO Week
seekingalpha.com
2020-08-23 06:48:55Three drug developers and a medical imaging company went public this past week, joined by eight SPACs. The week's eight SPAC IPOs raised $3.3 billion.
No data to display
6 Stocks Halted In Wednesday's Session: Here's Why
benzinga.com
2022-05-18 17:36:01A circuit breaker is an automatic, temporary trading halt on certain securities when the underlying stock is experiencing times of high volatility. It is a measure put in place to help restore and bring order to the markets.
Biologic Medicines-Focused Comera Life Sciences Turns To SPAC For NASDAQ Debut
benzinga.com
2022-01-31 14:52:51Comera Life Sciences Inc has agreed to go public through a merger with OTR Acquisition Corp (NASDAQ: OTRA), a blank-check company. The combined company will have an initial equity value of about $258.4 million.
U.S. IPO Weekly Recap: Breast Cancer Biotech Pops 158% In A 6-IPO Week
seekingalpha.com
2020-11-22 13:07:23In a scramble to go public ahead of the holiday, six IPOs and 15 SPACs went public this past week led by breast cancer biotech Olema Pharmaceuticals, which soared 158% on its first day. New filings continued to pour in, priming the IPO pipeline for an active end to 2020.
U.S. IPO Weekly Recap: Biotechs And SPACs Ride The Summer Wave In A 4 IPO Week
seekingalpha.com
2020-08-23 06:48:55Three drug developers and a medical imaging company went public this past week, joined by eight SPACs. The week's eight SPAC IPOs raised $3.3 billion.